NCT00069524View on ClinicalTrials.gov

Antihyperlipidemic Effects of Oyster Mushrooms

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

May 31, 2006

Conditions
HIV InfectionsHyperlipidemia
Interventions
DRUG

oyster mushroom

Trial Locations (1)

Unknown

General Clinical Research Center, San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

Office of Dietary Supplements (ODS)

NIH

lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00069524 - Antihyperlipidemic Effects of Oyster Mushrooms | Biotech Hunter | Biotech Hunter